It looks like you're offline.
Open Library logo
additional options menu
Open Library is running in limited-availability mode: login is disabled and some books may appear unavailable

MARC Record from Library of Congress

Record ID marc_loc_updates/v36.i19.records.utf8:5931615:2148
Source Library of Congress
Download Link /show-records/marc_loc_updates/v36.i19.records.utf8:5931615:2148?format=raw

LEADER: 02148nam a22003498a 4500
001 2008019288
003 DLC
005 20080506150820.0
008 080428s2009 flu b 001 0 eng
010 $a 2008019288
020 $a9781420053920 (hardcover : alk. paper)
020 $a1420053922 (hardcover : alk. paper)
035 $a(DNLM)101472544
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aQP801.H5$bT53 2009
060 10 $aQV 157$bT445 2009
082 00 $a612.8/2$222
245 04 $aThe third histamine receptor :$bselective ligands as potential therapeutic agents in CNS disorders /$cedited by Divya Vohora.
260 $aBoca Raton :$bCRC Press,$c2009.
263 $a0811
300 $ap. ;$ccm.
504 $aIncludes bibliographical references and index.
505 0 $aH3 receptor target: past, present and future perspectives from worldwide H3 experts / D. Vohora, S. Celanire -- The third histamine receptor: from discovery to clinics, a long-lasting love story at INSERM and Bioprojet / J.C. Schwartz -- Histamine as a neurotransmitter in brain / O. Selbach, H.L. Haas -- Philogeny, gene structure, expression and signaling / P. Panula ... [et al.] -- Drug discovery: from hits to clinical candidates / S. Celanire, F. Lebon, H. Stark -- Peripheral actions & therapeutic potential in periphery / G. Coruzzi, M. Adami -- Cognitive functions, attention deficit hyperactivity disorders & Alzheimer's disease / M.B. Passani ... [et al.] -- Sleep disorders / J.E. Shelton, T.W. Lovenberg, C. Dugovic -- Obesity / T.A. Esbenshade, M.E. Brune, M.I. Strakhova -- Epilepsy / D. Vohora, K.K. Pillai -- Schizophrenia / K.E. Browman ... [et al.] -- Other CNS disorders / P.L. Chazot, F.C. Shenton.
650 0 $aHistamine$xReceptors.
650 0 $aCentral nervous system$xDiseases$xChemotherapy.
650 0 $aAntihistamines.
650 12 $aHistamine H3 Antagonists$xtherapeutic use.
650 22 $aCentral Nervous System Diseases$xdrug therapy.
650 22 $aReceptors, Histamine H3$xmetabolism.
700 1 $aVohora, Divya.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0833/2008019288-d.html